Gemcitabine-induced thrombotic microangiopathy treated with eculizumab: a case report

BACKGROUND: Gemcitabine is a broadly used chemotherapeutic agent that can cause a rare but life-threatening complication called thrombotic microangiopathy (TMA). Early recognition is crucial as therapy options are limited. CASE DESCRIPTION: We report the case of a 46-year-old patient with pancreatic...

Descripción completa

Detalles Bibliográficos
Autores principales: Van den Eeckhaut, Lisa, Hannon, Heidi, Schurgers, Marie, Monsaert, Els, Claes, Kathleen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830318/
https://www.ncbi.nlm.nih.gov/pubmed/36636054
http://dx.doi.org/10.21037/jgo-22-509

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830318/
https://www.ncbi.nlm.nih.gov/pubmed/36636054
http://dx.doi.org/10.21037/jgo-22-509

Ejemplares similares